Treatment of co-occurring depression and substance dependence: Using meta-analysis to guide clinical recommendations

Psychiatric Annals

Volumn 38, Issue 11, 2008, Pages 730-738

  Nunes, Edward V ^a,b   Levin, Frances R ^a  

^a NY State Psychiatric Institute ^*  (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 56649117524     PISSN: 00485713     EISSN: None     Source Type: Journal    
DOI: 10.3928/00485713-20081101-05     Document Type: Review

References (50)

1. Hasin D, Nunes E, Meydan J. Comorbidity of alcohol, drug and psychiatric disorders: epidemiology. Kranzler HR, Tinsley JA, eds. In: Dual Diagnosis and Treatment: Substance Abuse and Comorbid Disorders. 2nd ed. Marcel Dekker: New York; 2004:1-34.
2. Regier DA, Farmer ME, Rae DS, et al. Comorbidity of mental disorders with alcohol and other drug abuse - results from the Epidemiological Catchment Area (ECA) Study. JAMA. 1990;263(19):2511-2518.
3. Kessler R, McGonagle K, Zhao S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: Results from the National Comorbidity Survey. Arch Gen Psychiatry. 1994;51(1):8-19.
4. nd ed. Tsuang MT, Tohen M, Zahner GEP, eds. Wiley-Liss;1995:179-197.
5. Grant B. Comorbidity between DSM-IV drug use disorders and major depression: Results of a national survey. J Subst Abuse. 1995;7(4):481-497.
6. Grant BF, Harford TC. Comorbidity between DSM-IV alcohol use disorders and major depression: results of a national survey. Drug Alcohol Depend. 1995;39(3):197-206.
7. Greenfield SF, Weiss RD, Muenz LR, et al. The effect of depression on return to drinking: a prospective study. Arch Gen Psychiatry. 1998;55(3):259-265.
8. Hasin D, Liu X, Nunes E, McCloud S, Samet S, Endicott J. Effects of major depression on remission and relapse of substance dependence. Arch Gen Psychiatry. 2002;59(4):375-380.
9. Brown SA, Schuckit MA. Changes in depression among abstinent alcoholics. J Stud Alcohol. 1988;49(5):412-417.
10. Brown SA, Inaba RK, Gillin JC, Schuckit MA, Stewart MA, Irwin MR. Alcoholism and affective disorder: clinical course of depressive symptoms. Am J Psychiatry. 1995;152(1):45-52.
11. Liappas J, Paparrigopoulos E, Tzavellas G, Christodoulou G. Impact of alcohol detoxification on anxiety and depressive symptoms. Drug Alcohol Depend. 2002;68(2):215-220.
12. Strain EC, Stitzer ML, Bigelow GE. Early treatment time course of depressive symptoms in opiate addicts. J Nerv Ment Dis. 1991;179(4):215-221.
13. Weddington WW, Brown BS, Haertzen CA, et al. Changes in mood, craving, and sleep during short-term abstinence reported by male cocaine addicts. Arch Gen Psych. 1990;47(9):861-868.
14. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Publishing; 1994.
15. Rosenthal R, DiMatteo MR. Meta-analysis: recent developments in quantitative methods for literature reviews. Annu Rev Psychol. 2001;52:59-82.
16. Sutton AJ, Abrams KR, Jones DR. An illustrated guide to the methods of meta-analysis. J Eval Clin Pract. 2001;7(2):135-148.
17. Smith CT, Williamson PR, Marson AG. An overview of methods and empirical comparison of aggregate data and individual patient data results for investigating heterogeneity in meta-analysis of time-to-event outcomes. J Eval Clin Pract. 2005;11(5):468-478.
18. Walsh BT, Seidman SN, Sysko R, Gould M. Placebo response in studies of major depression; variable, substantial, and growing. JAMA. 2002;287(14):1840-1847.
19. Nunes EV, Levin FR. Treatment of depression in patients with alcohol or other drug dependence: a meta-analysis. JAMA. 2004;291(15):1887-1896.
20. Altamura AC, Mauri MC, Girardi T, Panetta B. Alcoholism and depression: a placebo-controlled study with viloxazine. Int J Clin Pharm Res. 1990;10(5):293-298.
21. Roy A. Placebo controlled study of sertraline in depressed recently abstinent alcoholics. Biol Psychiatry. 1998;44(7):633-637.
22. Mason BJ, Kocsis JH, Ritvo EC, Cutler RB. A double blind, placebo controlled trial of desipramine for primary alcohol dependence stratified on the presence or absence of major depression. JAMA. 1996;275(10):761-767.
23. Nunes EV, Quitkin FM, Donovan SJ, et al. Imipramine treatment of opiate dependent patients with depressive disorders; A placebo controlled trial. Arch Gen Psychiatry. 1998;55(2):153-160.
24. Nunes EV, McGrath PJ, Quitkin FM, et al. Imipramine treatment of cocaine abuse; possible boundaries of efficacy. Drug Alcohol Depend. 1995;39(3):185-195.
25. Cornelius JR, Salloum IM, Ehler JG, et al. Fluoxetine in depressed alcoholics; A double blind, placebo controlled trial. Arch Gen Psychiatry. 1997;54(8):700-705.
26. Roy-Byrne PP, Pages KP, Russo JE, et al. Nefazodone treatment of major depression in alcohol-dependent patients: A double-blind, placebo-controlled trial. J Clin Psychopharmacology. 2000;20(2):129-136.
27. McGrath PJ, Nunes EV, Stewart JW, et al. Imipramine treatment of alcoholics with primary depression: a placebo controlled clinical trial. Arch Gen Psych. 1996;53(3):232-240.
28. Moak DH, Anton RF, Latham PK, Voronin KE, Waid RL, Durazo-Arvizu R. Sertraline and cognitive behavioral therapy for depressed alcoholics: Results of a placebo-controlled trial. J Clin Psychopharmacol. 2003;23(6):553-562.
29. Carpenter KM, Brooks AC, Vosburg SK, Nunes EV. The effect of sertraline and environmental context on treating depression and illicit substance use among methadone maintained opiate dependent patients: a controlled clinical trial. Drug Alcohol Depend. 2004;74(2):123-34.
30. Kleber HD, Weissman MM, Rounsaville BJ, Wilber CH, Prusoff BA, Riordan CE. Imipramine as treatment for depression in addicts. Arch Gen Psychiatry. 1983;40(6):649-653.
31. Schmitz JM, Averill P, Stotts AL, Moeller FG, Rhoades HM, Grabowski J. Fluoxetine treatment of cocaine dependent patients with major depressive disorder. Drug Alcohol Depend. 2001;63(3):207-214.
32. Petrakis I, Carroll KM, Nich C, Gordon L, Kosten T, Rounsaville B. Fluoxetine treatment of depressive disorders in methadone maintained opiate addicts. Drug Alcohol Depend. 1998;50(3):221-226.
33. Pettinati HM, Volpicelli JR, Luck G, Kranzler HR, Rukstalis MR, Cnaan A. Doubleblind clinical trial of sertraline treatment for alcohol dependence. J Clin Psychopharmacology. 2001;21(2):143-153.
34. Hamilton MA. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56-62.
35. Torrens M, Fonseca F, Mateu G, Farre M. Efficacy of antidepressants in substance use disorders with and without comorbid depression. A systematic review and meta-analysis. Drug Alcohol Depend. 2005;78(1):1-22.
36. Hall SM, Reus VI, Muñoz RF, et al. Nortriptyline and cognitive-behavioral therapy in the treatment of cigarette smoking. Arch Gen Psychiatry. 1998;55(8):683-690.
37. Nunes EV, Sullivan MA, Levin FR. Treatment of depression in patients with opiate dependence. Biol Psychiatry. 2004;56(10):793-802.
38. Higgins ST, Sigmon SC, Wong CJ, et al. Community reinforcement therapy for cocaine-dependent outpatients. Arch Gen Psychiatry. 2003;60(10):1043-1052.
39. Petrakis IL, Poling J, Levinson C, et al; VA New England VISN I MIRECC Study Group. Naltrexone and disulfiram in patients with alcohol dependence and comorbid psychiatric disorders. Biol Psychiatry. 2005;57(10):1128-1137.
40. Petrakis I, Ralevski E, Nich C, et al; VA VISN I MIRECC Study Group. Naltrexone and disulfiram in patients with alcohol dependence and current depression. J Clin Psychopharmacol. 2007;27(2):160-165.
41. Hasin D, Samet S, Nunes E, et al. Diagnosis of comorbid psychiatric disorders in substance users assessed with the Psychiatric Research Interview for Substance and Mental Disorders for DSM-IV. Am J Psychiatry. 2006;163(4):689-696.
42. Nordstrom BR, Levin FR. Treatment of cannabis use disorders: a review of the literature. Am J Addict. 2007;16(5):331-42.
43. Degenhardt L, Hall W, Lynskey M. Exploring the association between cannabis use and depression. Addiction. 2003;98(11):1493-1504.
44. Kranzler HR, Mueller T, Cornelius J, et al. Sertraline treatment of co-occurring alcohol dependence and major depression. J Clin Psychopharmacol. 2006;26(1):13-20.
45. Rounsaville BJ, Kosten TR, Weissman MM, Kleber HD. Prognostic significance of psychopathology in treated opiate addicts; a 2.5 year follow up study. Arch Gen Psychiatry. 1986;43(8):739-745.
46. Rounsaville BJ, Dolinsky ZS, Babor TF, Meyer RE. Psychopathology as a predictor of treatment outcome in alcoholics. Arch Gen Psychiatry. 1987;44(6):505-513.
47. Kranzler HR, Burleson JA, Brown J, Babor TF. Fluoxetine treatment seems to reduce the beneficial effects of cognitive-behavioral therapy in type B alcoholics. Alcohol Clin Exp Res. 1996;20(9):1534-1541.
48. Pettinati HM, Volpicelli JR, Kranzler HR, Luck G, Rustalis MR, Cnaan A. Sertraline treatment for alcohol dependence: interactive effects of medication and alcoholic subtype. Alcohol Clin Exp Res. 2000;24(7):1041-1049.
49. Brady KT, Sonne S, Anton RF, Randall CL, Back SE, Simpson K. Sertraline in the treatment of co-occurring alcohol dependence and posttraumatic stress disorder. Alcohol Clin Exp Res. 2005;29(3):395-401.
50. Riggs PD, Mikulich-Gilbertson SK, Davies RD, Lohman M, Klein C, Stover SK. A randomized controlled trial of fluoxetine and cognitive behavioral therapy in adolescents with major depression, behavior problems, and substance use disorders. Arch Pediatr Adolesc Med. 2007;161(11):1026-1034.